The ratio between them functions like a tipping point: a high Bcl-2/Bax ratio means the cell is likely to survive, and a low ratio means it's more likely to undergo apoptosis
This effect aligns with the product's purpose-supporting natural GLP-1 signaling from the gut
Primary outcomes: Results Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity
NHS treatment is typically initiated and supervised by specialist weight management services, with specific duration limits (up to 2 years for semaglutide) and continuation criteria based on weight loss targets
PlexusDx integrates genetic insights into your full treatment plan, addressing not just GLP-1 sensitivity but also metabolic rate, hunger signaling, and nutrient utilization
OUR STORY Developed for Doctors